Telomere dynamics in Fancg-deficient mouse and human cells

Blood

Volumn 104, Issue 13, 2004, Pages 3927-3935

  Franco, Sonia ^b   Van De Vrugt, Henri J ^b   Fernández, Piedad ^b   Aracil, Miguel ^b   Arwert, Fre ^b   Blasco, María A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; FANCONI ANEMIA GROUP G PROTEIN; MITOMYCIN C; PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CHROMOSOME; CONTROLLED STUDY; CYTOGENETICS; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; FANCONI ANEMIA; FEMALE; FIBROBLAST; GAMMA RADIATION; GERM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TELOMERE;

EID: 10244229101     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-10-3626     Document Type: Article

References (70)

1. Blackburn EH. Switching and signalling at the telomere. Cell. 2001;106:661-673.
2. de Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532-540.
3. Bailey SM, Meyne J, Chen DJ, et al. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A. 1999;96:14899-14904.
4. Hsu H-L, Gilley D, Galande SA, et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 2000;14:2807-2812.
5. Samper E, Goytisolo F, Slijepcevic P, van Buul P, Blasco MA. Mammalian Ku86 prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 2000;1:244-252.
6. Goytisolo F, Samper E, Edmonson S, Taccioli GE, Blasco MA. Absence of DNA-PKcs in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol. 2001;21:3642-3651.
7. d'Adda di Fagagna F, Hande MP, Tong WM, et al. Effects of DNA non-homologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol. 2001;11:1192-1196.
8. Espejel S, Franco, S., Rodríguez-Perales, et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 2002;21:2207-2219.
9. Espejel S, Franco S, Sgura A, et al. Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J. 2002;21: 6275-6287.
10. Jaco I, Muñoz P, Goytisolo F, et al. Role of mammalian Rad54 in telomere length maintenance. Mol Cell Biol. 2003;23:5572-5580.
11. Tarsounas M, Muñoz P, Claas A, et al. Telomere maintenance requires the RAD51D recombination/repair protein. Cell. 2004;117:337-347.
12. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43:405-413.
13. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A. 1995;92:9082-9086.
14. Mitchell JR, Wood E, Collins K. Atelomerase component is defective in human disease dyskeratosis congenita. Nature. 1999;402;551-555.
15. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432-434.
16. Samper E, Fernandez P, Eguia R, et al. Long-term repopulating ability of telomerase-deficient murine hematopoietic cells. Blood. 2002;99:2767-2775.
17. Allsop RC, Morin GB, DePinho R, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 2003;102:517-520.
18. Ball SE, Gibson FM, Rizzo S, et al. Progressive telomere shortening in aplastic anemia. Blood. 1998;91:3582-3592.
19. Brümmendorf T, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;15:895-900.
20. Baerlocher GM, Röth A, Lansdorp PM. Telomeres in hematopoietic cells. Ann N Y Acad Sci. 2003; 996:44-48.
21. D'Andrea AD, Grompe M. The Fanconi anaemia/ BRCA pathway. Nat Rev Cancer. 2003;3:23-34.
22. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol. 2004;24:123-134.
23. Venkitaraman AR. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat Rev Cancer. 2004;4:266-276.
24. Leteurtre F, Li X, Guardiola P, et al. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol. 1999;105: 883-893.
25. Hanson H, Mathew CG, Docherty Z, et al. Telomere shortening in Fanconi anemia demonstrated by a direct approach. Cytogenet Cell Genet. 2001;93:203-206.
26. Adelfalk C, Lorenz M, Serra V, et al. Accelerated telomere shortening in Fanconi anemia fibroblasts - a longitudinal study. FEBS Lett. 2001; 506:22-26.
27. Callen E, Samper E, Ramirez MJ, et al. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum Mol Genet. 2002;11:439-444.
28. Li X, Leteurtre F, Rocha V, Guardiola P, et al. Abnormal telomere metabolism in Fanconi's anemia correlates with genomic instability and the probability of developing severe aplastic anemia. Br J Hematol. 2003;120:836-845.
29. de Winter JP, Waisfisz Q, Rooimans MA, et al. The fanconi anemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281-283.
30. Blom E, van de Vrugt HJ, de Winter JP, Arwert F, Joenje H. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair. 2004;3:77-84.
31. Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG. Direct interaction of the Fanconi anemia protein FANCG with BRCA2/ FANCD1. Hum Mol Genet. 2003;12:2503-2510.
32. Koomen M, Cheng NC, van de Vrugt HJ, et al. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum Mol Genet. 2002;11:273-281.
33. van de Vrugt HJ, Koomen M, Berns MA, et al. Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg. Genes Cells. 2002;7:333-342.
34. Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:1-3.
35. INK4a. Mol Cell. 2004;501-513.
36. Rufer N, Dragowska W, Thornbury G, et al. Telomere dynamics in lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743-747.
37. McIlrath J, Bouffler SD, Samper E, et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 2001;61:912-915.
38. Kipling D, Cooke HJ. Hypervariable ultra-long telomeres in mice. Nature. 1990;347:400-402.
39. Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol. 1999;144:589-601.
40. Yang Y, Kuang Y, De Oca RM, et al. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood. 2001;98:3435-3440.
41. Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet. 1996;12:200-204.
42. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interference RNAs in mammalian cells. Science. 2002;296: 550-553.
43. Goytisolo F, Blasco MA. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene. 2002;21:584-591.
44. Latre L, Tusell L, Martin M, et al. Shortened telomeres join to DNA breaks interfering with their correct repair. Exp Cell Res. 2003;287:282-288.
45. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene. 2002;21:564-579.
46. Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene. 2002;21:598-610.
47. Yamamoto K, Ishiai M, Matsushita N, et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol. 2003;23:5421-5430.
48. Aubé M, Lafrance M, Brodeur I, Delisle M-C, Carreau M. Fanconi anemia genes are highly expressed in primitive CD34+ hematopoietic cells. BMC Blood Disord. 2003;3:1-9.
49. Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol. 1999;27:1667-1674.
50. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999; 94:1-8.
51. Li X, Plett PA, Yang Y, et al. Fanconi anemia type C deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control. Blood. 2003; 102:2081-2084.
52. Hadjur S, Jirik FR. Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. Blood. 2003;101:3877-3884.
53. Allsop RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med. 2001;193:917-924.
54. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107:67-77.
55. -/- mice with short telomeres. EMBO Rep. 2001;2:800-807.
56. Wong JC, Alon N, Mckerlie C, Huang JR, Meyn MS, Buchwald M. Targeted disruption of exons 1 to 6 of the Fanconi anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum Mol Genet. 2003;12:2063-2076.
57. Houghtaling S, Timmers C, Noll M, et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 2003;17:2021-2035.
58. Hemann MT, Rudolph KL, Strong MA, De Pinho RA, Chin L, Greider CW. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol Biol Cell. 2001;12:2023-2030.
59. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89: 10114-10118.
60. Martens UM, Chavez EA, Poon SS, Schmoor C, Lansdorp PM. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res. 2000;256:291-299.
61. Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in hematological neoplasia. Oncogene. 2002;21:680-687.
62. Marciniak R, Guarente L. Testing telomerase. Nature. 2001;413:370-372.
63. Wolthers KC, Bea G, Wisman A, et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science. 1996; 274:1543-1547.
64. Notaro R, Cimmino A, Tabarini D, Luzzatto L. In vivo telomere dynamics of human hematopoietc cells. Proc Natl Acad Sci U S A. 1997;94:13782-13785.
65. Pagano G, Youssoufian H. Fanconi anemia proteins: major roles in cell protection against oxidative damage. BioEssays. 2003;25:589-595.
66. Park S-J, Ciccone SLM, Beck BD, et al. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem. 2004;279:30053-30059.
67. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339-344.
68. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7: 249-262.
69. Hirsch B, Shimamura A, Moreau L, et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood. 2004;103:2554-2559.
70. Lensch MW, Tishkowitz M, Christianson TA, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood. 2003;102:7-16.